Astria Therapeutics

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$0
EBITDA
-35,820
-36,995
-29,591
-29,014
EBIT
-35,820
-36,995
-29,547
-29,014
Net Income
-33,052
-33,709
-25,626
-24,534
Net Change In Cash
0
0
0
0
Free Cash Flow
-36,648
-34,018
-17,362
-27,985
Cash
76,319
54,385
59,820
80,899
Basic Shares
58,005
58,005
56,434
56,485

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
EBITDA
-94,260
-83,030
-51,834
-194,976
EBIT
-111,558
-67,831
-53,503
-30,359
Net Income
-94,260
-72,891
-50,165
-194,912
Net Change In Cash
0
0
0
0
Cost of Revenue
-65,941
Free Cash Flow
-81,537
-68,470
-43,624
-30,172
Cash
59,820
175,530
20,525
86,508
Basic Shares
56,161
30,123
14,620
8,925

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.57
2025-03-31
-$0.58
2024-12-31
-$0.44